melanotan-ii has been researched along with Binge Alcohol Consumption in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Navarro, M; Olney, JJ; Sprow, GM; Thiele, TE | 1 |
| Carvajal, F; Cubero, I; Lerma-Cabrera, JM; Navarro, M; Picker, MJ; Thiele, TE | 1 |
2 other study(ies) available for melanotan-ii and Binge Alcohol Consumption
| Article | Year |
|---|---|
The protective effects of the melanocortin receptor (MCR) agonist, melanotan-II (MTII), against binge-like ethanol drinking are facilitated by deletion of the MC3 receptor in mice.
Topics: alpha-MSH; Animals; Binge Drinking; Ethanol; Female; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptides, Cyclic; Receptor, Melanocortin, Type 3 | 2014 |
Evidence that Melanocortin Receptor Agonist Melanotan-II Synergistically Augments the Ability of Naltrexone to Blunt Binge-Like Ethanol Intake in Male C57BL/6J Mice.
Topics: alpha-MSH; Animals; Binge Drinking; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Ethanol; Male; Mice; Mice, Inbred C57BL; Naltrexone; Narcotic Antagonists; Peptides, Cyclic; Receptors, Melanocortin | 2015 |